G&E Herbal Biotechnology (4911) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 德英

G&E Herbal Biotechnology (4911) reported revenue of NT$11.6 million for Oct 2026, -50.7% year on year and +1.4% from the previous month. Revenue for Jan–Oct 2026 was NT$112.6 million (-57.3% year on year).

In Oct 2026, it ranked No. 133 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$23.6 million24/10Nov 2024 NT$23.8 millionDec 2024 NT$24.4 millionJan 2025 NT$27.4 millionFeb 2025 NT$26.2 million25/02Mar 2025 NT$26.5 millionApr 2025 NT$25.9 millionMay 2025 NT$26.9 millionJun 2025 NT$27.3 million25/06Jul 2025 NT$27.9 millionAug 2025 NT$25.9 millionSep 2025 NT$26 millionOct 2025 NT$23.6 million25/10Nov 2025 NT$22.8 millionDec 2025 NT$22.8 millionJan 2026 NT$10.7 millionFeb 2026 NT$10.8 million26/02Mar 2026 NT$10.6 millionApr 2026 NT$11.3 millionMay 2026 NT$11.6 millionJun 2026 NT$11.6 million26/06Jul 2026 NT$11.3 millionAug 2026 NT$11.6 millionSep 2026 NT$11.4 millionOct 2026 NT$11.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$11.6 million-50.7%+1.4%
Sep 2026NT$11.4 million-56.0%-1.1%
Aug 2026NT$11.6 million-55.3%+2.4%
Jul 2026NT$11.3 million-59.5%-2.3%
Jun 2026NT$11.6 million-57.6%-0.3%
May 2026NT$11.6 million-56.9%+2.5%
Apr 2026NT$11.3 million-56.4%+6.3%
Mar 2026NT$10.6 million-59.8%-2.0%
Feb 2026NT$10.8 million-58.7%+1.1%
Jan 2026NT$10.7 million-60.9%-53.0%
Dec 2025NT$22.8 million-6.5%+0.2%
Nov 2025NT$22.8 million-4.3%-3.2%
Oct 2025NT$23.6 million-0.2%-9.5%
Sep 2025NT$26 million+12.0%+0.5%
Aug 2025NT$25.9 million+30.4%-7.1%
Jul 2025NT$27.9 million+45.5%+2.3%
Jun 2025NT$27.3 million+34.0%+1.5%
May 2025NT$26.9 million+33.7%+3.6%
Apr 2025NT$25.9 million+35.6%-2.1%
Mar 2025NT$26.5 million+36.1%+0.8%
Feb 2025NT$26.2 million+49.0%-4.3%
Jan 2025NT$27.4 million+49.6%+12.3%
Dec 2024NT$24.4 million+34.3%+2.5%
Nov 2024NT$23.8 million+51.9%+0.9%
Oct 2024NT$23.6 million+57.4%+1.6%

Jan–Oct 2026 cumulative: NT$112.6 million (-57.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: G&E Herbal Biotechnology vs PEC / G&E Herbal Biotechnology vs Lotus Pharm / G&E Herbal Biotechnology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

公司行銷團隊建置中

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16